92 related articles for article (PubMed ID: 25245602)
1. PIK3CA in ovarian clear cell carcinoma.
Zannoni GF; Improta G; Fraggetta F
Hum Pathol; 2014 Dec; 45(12):2514. PubMed ID: 25245602
[No Abstract] [Full Text] [Related]
2. Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
Rahman M; Nakayama K; Rahman MT; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
Hum Pathol; 2012 Dec; 43(12):2197-206. PubMed ID: 22705003
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations in ovarian cancer.
Campbell IG; Russell SE; Phillips WA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7042; author reply 7042-3. PubMed ID: 16203798
[No Abstract] [Full Text] [Related]
4. PI3KCA in ovarian clear cell carcinoma-reply.
Nakayama K; Kyo S
Hum Pathol; 2014 Dec; 45(12):2515. PubMed ID: 25257578
[No Abstract] [Full Text] [Related]
5. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.
Jiang G; Huang Z; Zhang S; Wang L
Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
[TBL] [Abstract][Full Text] [Related]
7. Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?
Gounaris I; Charnock-Jones DS; Brenton JD
J Pathol; 2011 Oct; 225(2):157-60. PubMed ID: 21898874
[TBL] [Abstract][Full Text] [Related]
8. PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Kato N; Sato Y; Kamataki A; Fukase M; Uchigasaki S; Kurose A
Hum Pathol; 2019 Apr; 86():32-37. PubMed ID: 30496799
[TBL] [Abstract][Full Text] [Related]
9. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA.
Hoshino H; Inoue D; Shinagawa A; Yoshida H; Shigeto S; Matsuda K; Akama TO; Yoshida Y; Kobayashi M
Hum Cell; 2024 Jul; 37(4):1184-1193. PubMed ID: 38573494
[TBL] [Abstract][Full Text] [Related]
11. Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.
Chandler RL; Damrauer JS; Raab JR; Schisler JC; Wilkerson MD; Didion JP; Starmer J; Serber D; Yee D; Xiong J; Darr DB; Pardo-Manuel de Villena F; Kim WY; Magnuson T
Nat Commun; 2015 Jan; 6():6118. PubMed ID: 25625625
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.
Itamochi H; Kato M; Nishimura M; Oumi N; Oishi T; Shimada M; Sato S; Naniwa J; Sato S; Nonaka M; Kudoh A; Terakawa N; Kigawa J; Harada T
Hum Cell; 2013 Sep; 26(3):121-7. PubMed ID: 23430509
[TBL] [Abstract][Full Text] [Related]
13. Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).
Jiang W; Ye S; Xiang L; Yang W; He T; Pei X; Guo L; Yang H
J Ovarian Res; 2018 Jul; 11(1):58. PubMed ID: 29986747
[TBL] [Abstract][Full Text] [Related]
14. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma.
Abe A; Minaguchi T; Ochi H; Onuki M; Okada S; Matsumoto K; Satoh T; Oki A; Yoshikawa H
Hum Pathol; 2013 Feb; 44(2):199-207. PubMed ID: 22955107
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations in advanced ovarian carcinomas.
Wang Y; Helland A; Holm R; Kristensen GB; Børresen-Dale AL
Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
Huang HN; Huang WC; Lin CH; Chiang YC; Huang HY; Kuo KT
Hum Pathol; 2014 Nov; 45(11):2318-25. PubMed ID: 25281027
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis-associated ovarian carcinomas.
Nissenblatt M
N Engl J Med; 2011 Feb; 364(5):482-3; author reply 484-5. PubMed ID: 21288105
[No Abstract] [Full Text] [Related]
20. Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for Unexpected "Vertigo".
Piermattei A; Santoro A; Angelico G; Inzani F; Valente M; Pettinato A; Vatrano S; Scambia G; Fraggetta F; Zannoni GF
Int J Gynecol Pathol; 2020 Jan; 39(1):68-71. PubMed ID: 30252727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
